🇺🇸 FDA
Patent

US 6048870

3, 5, and/or 6 substituted analogues of swainsonine processes for their preparation and their use as therapeutic agents

expired A61PA61P31/00A61P35/00

Quick answer

US patent 6048870 (3, 5, and/or 6 substituted analogues of swainsonine processes for their preparation and their use as therapeutic agents) held by GlycoDesign Holdings Ltd. expires Mon Apr 06 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
GlycoDesign Holdings Ltd.
Grant date
Tue Apr 11 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 06 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61P, A61P31/00, A61P35/00, A61P37/04